MagForce AG

DB:MF6 Stock Report

Market Cap: €366.9k

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

MagForce Valuation

Is MF6 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of MF6 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate MF6's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate MF6's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for MF6?

Key metric: As MF6 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for MF6. This is calculated by dividing MF6's market cap by their current revenue.
What is MF6's PS Ratio?
PS Ratio0.3x
Sales€1.08m
Market Cap€366.87k

Price to Sales Ratio vs Peers

How does MF6's PS Ratio compare to its peers?

The above table shows the PS ratio for MF6 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average5.2x
AUG Audientes
12.6xn/a€6.9m
GME Geratherm Medical
0.8x1.9%€15.0m
NN6 NanoRepro
5.5xn/a€19.6m
AAQ1 aap Implantate
1.9xn/a€22.4m
MF6 MagForce
0.3xn/a€366.9k

Price-To-Sales vs Peers: MF6 is good value based on its Price-To-Sales Ratio (0.3x) compared to the peer average (6.2x).

Price to Sales Ratio vs Industry

How does MF6's PS Ratio compare vs other companies in the DE Medical Equipment Industry?

4 CompaniesPrice / SalesEstimated GrowthMarket Cap
Industry Avg.3.5x6.0%
MF6 MagForce
 0.3xn/aUS$404.27k
DRW3 Drägerwerk KGaA
0.2x4.2%US$827.50m
PHH2 Paul Hartmann
0.3xn/aUS$791.49m
MF6 0.3xIndustry Avg. 3.5xNo. of Companies4PS01.63.24.86.48+
4 CompaniesEstimated GrowthMarket Cap
Industry Avg.3.5x14.2%
MF6 MagForce
 0.3xn/aUS$404.27k
No more companies

Price-To-Sales vs Industry: MF6 is good value based on its Price-To-Sales Ratio (0.3x) compared to the European Medical Equipment industry average (3.3x).

Price to Sales Ratio vs Fair Ratio

What is MF6's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

MF6 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.3x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate MF6's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Shandong Weigao Group Medical Polymer

HK$20.1b

Engages in the research and development, production, wholesale, and sale of medical devices in the People’s Republic of China.

UK2

HK$0.52

7D

-1.0%

1Y

-38.8%

LNA Santé

€244.4m

Engages in the management and operation of health establishments.

2N3

€23.25

7D

-6.1%

1Y

16.0%

Top Glove Corporation Bhd

RM 7.8b

An investment holding company, manufactures, trades in, and sells gloves in Malaysia, Thailand, the People’s Republic of China, and internationally.

5OU

RM 0.98

7D

0.5%

1Y

-82.5%